Chemclin Diagnostics Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 2/6
Chemclin Diagnostics has been growing earnings at an average annual rate of 1.8%, while the Medical Equipment industry saw earnings growing at 6.4% annually. Revenues have been declining at an average rate of 0.8% per year. Chemclin Diagnostics's return on equity is 9.9%, and it has net margins of 31.4%.
Wichtige Informationen
1.8%
Wachstumsrate der Gewinne
-8.3%
EPS-Wachstumsrate
| Medical Equipment Wachstum der Industrie | 16.0% |
| Wachstumsrate der Einnahmen | -0.8% |
| Eigenkapitalrendite | 9.9% |
| Netto-Marge | 31.4% |
| Letzte Ertragsaktualisierung | 30 Sep 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Little Excitement Around Chemclin Diagnostics Co., Ltd.'s (SHSE:688468) Earnings
Sep 28
Concerns Surrounding Chemclin Diagnostics' (SHSE:688468) Performance
May 06Little Excitement Around Chemclin Diagnostics Co., Ltd.'s (SHSE:688468) Earnings
Apr 30Chemclin Diagnostics (SHSE:688468) Shareholders Will Want The ROCE Trajectory To Continue
Mar 27Aufschlüsselung der Einnahmen und Ausgaben
Wie Chemclin Diagnostics Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Sep 24 | 444 | 139 | 141 | 67 |
| 30 Jun 24 | 452 | 147 | 137 | 62 |
| 31 Mar 24 | 456 | 151 | 139 | 67 |
| 31 Dec 23 | 445 | 147 | 133 | 65 |
| 30 Sep 23 | 451 | 155 | 127 | 64 |
| 30 Jun 23 | 461 | 160 | 133 | 68 |
| 31 Mar 23 | 445 | 148 | 129 | 67 |
| 31 Dec 22 | 465 | 153 | 135 | 68 |
| 30 Sep 22 | 475 | 153 | 136 | 70 |
| 30 Jun 22 | 457 | 142 | 136 | 68 |
| 31 Mar 22 | 471 | 144 | 142 | 71 |
| 31 Dec 21 | 471 | 143 | 143 | 67 |
| 30 Sep 21 | 478 | 148 | 149 | 59 |
| 30 Jun 21 | 504 | 156 | 148 | 64 |
| 31 Mar 21 | 479 | 144 | 139 | 58 |
| 31 Dec 20 | 418 | 117 | 129 | 54 |
| 31 Dec 19 | 455 | 141 | 141 | 55 |
| 31 Dec 18 | 366 | -424 | 633 | 50 |
| 31 Dec 17 | 319 | -435 | 621 | 31 |
Qualität der Erträge: 688468 has high quality earnings.
Wachsende Gewinnspanne: 688468's current net profit margins (31.4%) are lower than last year (34.3%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 688468 has become profitable over the past 5 years, growing earnings by 1.8% per year.
Beschleunigtes Wachstum: 688468's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Erträge im Vergleich zur Industrie: 688468 had negative earnings growth (-9.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 688468's Return on Equity (9.9%) is considered low.